Cannabis Stock Bubble
2018 - 2021
Peak Value
92.48
Crash Value
32.85
Duration
11 months
Overview
The 2018-2021 cannabis stock bubble was not a single parabola. It is better described as a double peaked speculative cycle: first, excitement over Canada’s 2018 federal legalization, then, after a brutal washout, a second surge in late 2020 and early 2021 driven by U.S. reform hopes, merger activity, and meme-stock dynamics.
The Narrative
The cannabis bubble was, at its core, driven by expectations of global policy change and explosive future growth. Investors were not only buying existing cannabis company stocks; they were buying the possibility that Canada’s newly legal market would become a globally accepted and that U.S. federal restrictions would eventually disappear. The listings of Tilray Brands on Nasdaq and Canopy Growth Corporation on the NYSE were important because they provided scarce, tradable stocks through which international investors could "prove" those expectations. Canadian cannabis companies became major beneficiaries of later rallies precisely because U.S. exchange listings allowed global investors to access the sector.
That optimism accelerated capital inflows before the market fundamentals had developed. Cannabis companies raised nearly $14 billion in 2018, more than four times the previous year’s amount. Constellation Brands’s C$5 billion investment in Canopy Growth gave the company a level of financial capacity far beyond what a typical agricultural start-up could achieve. Mergers, acquisitions, and stock-funded expansions followed the same logic: scale was treated as a competitive advantage, so companies pursued “global leadership” through international expansion, pharmaceutical ambitions, wellness products, and future consumer brands. The problem was that stock market enthusiasm created production capacity and soaring stock valuations much faster than the market could generate demand.
By the time Canada legalized the use cannabis on October 17, 2018, much of the first speculative wave had already occurred. The sector entered 2018 year closing high of 180.02, before falling sharply in February after Attorney General Jeff Sessions’ decision in January 2018 to rescind the Obama-era Cole Memo sent shockwaves through the legal cannabis industry. It removed federal non-interference guidelines that had allowed state-legal marijuana markets to thrive, replacing them with a directive leaving prosecution decisions to individual U.S. Attorneys.
The market recovered in August and September as renewed excitement around Constellation Brands’ investment in Canopy Growth and Tilray’s U.S.-listing-driven surge revived expectations of a globally dominant cannabis industry. However, legalization day itself exposed the gap between investor expectations and market reality: legal access remained limited, with store shortages even in major cities such as Toronto and Vancouver.
The first major correction came in 2019 because the legal market existed, but it developed far more slowly and unevenly than valuation models assumed. Ontario introduced a lottery-based retail system and opened only a fraction of the stores investors expected. The legal market faced supply problems, provincial differences, product restrictions, and significant pricing disadvantages compared with the illicit market. Research later estimated that legal cannabis captured only 23.7% of total Canadian cannabis consumption by September 2019, while government data showed legal cannabis was sold at a substantial premium compared with illicit alternatives. CannTrust Holdings’s licence suspension in September 2019 further damaged confidence by showing that aggressive growth narratives could conceal basic regulatory and operational failures.
The pandemic created the conditions for a second phase of speculation. The sector reached its low point on March 18, 2020, but cannabis sales proved resilient, and several jurisdictions classified cannabis businesses as essential, strengthening the perception that the industry had entered a more legitimate phase. The November 2020 U.S. election then provided a new narrative: investors shifted their focus away from disappointing Canadian results and toward the possibility of U.S. legalization, expanded state markets, a more supportive administration, and federal reform. The sector had increased by 62% in the fourth quarter of 2020, followed by another 27.8% increase in January 2021.
This second surge relied on expectations of U.S. policy unlocking the growth that Canadian companies had failed to achieve. The Aphria Inc.–Tilray merger created a new “largest global cannabis company” narrative, while the Georgia Senate runoff results encouraged investors to revalue the sector based on anticipated Washington policy changes. At the same time, social-media-driven speculation from communities such as Reddit's WallStreetBets accelerated buying in cannabis companies. The February 2021 rally was increasingly driven by trading momentum rather than improvements in sales, margins, or operating performance.
The market structure itself became part of the bubble. In February 2021, Tilray’s short interest increased sharply, and retail traders began treating cannabis stocks as part of the same speculative environment as other heavily shorted stocks. Once price movements became the main investment argument, the rally lost a durable connection to business fundamentals. The reversal began almost immediately, and the remainder of 2021 became a prolonged decline as expected reforms failed to arrive, oversupply continued, and companies moved from expansion toward cost cutting and restructuring.
References:
Global Cannabis Stock Index – New Cannabis Ventures
The Cannabis Act: The Facts – Health Canada
Reuters – Canada Weed Stocks Come Off High as Challenges Loom Before Legalization
Justice Department Issues Memo on Marijuana Enforcement – U.S. Department of Justice
Reuters – Canada's Aurora Cannabis to Buy Rival to Create World's Most Valuable Weed Firm
Reuters – Canadian Cannabis Company Tilray Soars in Nasdaq Debut
Yahoo Finance – Tilray Dethrones Canopy Growth as Most Valuable Cannabis Company
Reuters – Ontario's Slow Rollout of Weed Outlets Could Help Black Market
Reuters – Pot Producer CannTrust's License to Produce, Sell Cannabis Suspended
Global Cannabis Stocks End February with Another Big Gain – New Cannabis Ventures
Reuters – Pot Stocks High as Democrats on Brink of Controlling U.S. Senate
CSA Staff Notice 51-352 (Revised) – Issuers with U.S. Marijuana-Related Activities
Warning Signs
- Valuations moved far ahead of business fundamentals. Investors priced cannabis companies based on expectations of future dominance rather than current revenues, profitability, or proven demand.
- Rapid flow of capital into the industry before the market was ready. Companies raised large amounts of money and expanded aggressively, creating excess production capacity that outpaced actual consumer demand.
- The gap between the investment narrative and market reality became clear after legalization. Limited retail access, distribution problems, higher legal prices, and continued competition from the illegal market showed that adoption would be slower than investors expected.
- The later stages of the rally became driven by speculation rather than fundamentals. Social-media hype, short-interest trading, and momentum buying pushed stock prices higher, but once enthusiasm faded, the lack of underlying business support led to a sharp decline.
Who Benefited
The cleanest beneficiaries were companies that sold stock or raised capital during periods of intense investor enthusiasm. The sector raised nearly $14 billion in 2018, while Canopy Growth gained access to C$5 billion through Constellation Brands’ investment. During the second rally, cannabis companies raised approximately $1.38 billion through equity offerings in the first five weeks of 2021 alone. Even though many investors later experienced poor long-term returns, the sector still acquired significant amounts of capital.
A second, less affected group from the bust were beneficiaries that came from supplementary and financing-focused businesses. Innovative Industrial Properties was a clear example, reaching an all-time high in December 2020 and reporting approximately $204.6 million in revenue and $112.6 million in net income attributable to common stockholders in 2021, representing year-over-year increases of 75%. This demonstrated that the bubble created genuine value in “picks-and-shovels” segments, including property owners, equipment providers, compliance software companies, and service providers, even as many cannabis cultivators struggled to convert growing demand into sustainable profits.
Who Lost
The most obvious losers were late cycle public shareholders. By the end of 2021, the Global Cannabis Stock Index had fallen 64.5% from its February 10, 2021 closing high and remained 81.8% below its early-2018 closing high. Investors who entered during the final confirmation phases of the bubble (either around Canada’s legalization peak or the 2021 U.S. reform and meme-stock surge) suffered the largest losses.
Another major group of losers consisted of employees and communities connected to overbuilt cultivation operations. The rapid expansion of production capacity created facilities and jobs that the market could not support. Canopy Growth closed two Canadian greenhouses in March 2020, eliminated around 500 job positions, and recorded significant charges related to restructuring. By early 2021, the company had reduced its workforce substantially compared with the previous year. Aurora Cannabis followed a similar path, announcing hundreds of job cuts, large impairment charges, facility closures, and further workforce reductions as it attempted to adjust to excess production capacity.
A final group of losers included shareholders of companies where governance failures damaged investor confidence. CannTrust’s licence suspension in September 2019 after regulators discovered unlicensed cultivation harmed both the company and the credibility of the wider cannabis sector. In speculative markets, governance problems have an outsized impact because they undermine confidence not only in individual companies but also in the broader investment narrative supporting the industry.
Market Impact
The cannabis bubble brought the industry into mainstream financial markets, attracting billions in investment and securing places in major stock indices. However, when growth failed to meet expectations, cannabis stocks suffered a prolonged decline, with late-arriving investors experiencing the largest losses.
The aftermath included facility closures, layoffs, and large asset write-downs as companies scaled back expansion plans built during the boom. Governance failures also damaged confidence in the sector and increased regulatory scrutiny.
Although the industry survived, the crash showed the risks of building valuations and production capacity on expectations that proved too optimistic.
Lessons Learned
Legalization is not the same thing as monetization. A product can move from illegal to legal and still remain hard to distribute, expensive relative to illicit supply, and structurally unprofitable for many operators.
Policy-dependent sectors should be valued on the path to cash flow, not on the maximum imaginable total addressable market. The further a rally depends on “if Washington changes everything,” “if the illicit market disappears,” or “if brand power eventually fixes commodity economics,” the more fragile it becomes.
Discussion
(0)Comments are currently locked for this bubble.